logo

For the Inventor, By the Inventor

Kanazawa, Japan

Yukihiko Kameda

This inventor holds 11 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1977-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukihiko Kameda. Retrieved from https://idiyas.com/inventor/yukihiko-kameda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 89(Granted Patents)


Location History:

  • Toyonaka, JA (1977)
  • Osaka, JA (1977)
  • Kanazawa, JA (1978)
  • Kanazawa, JP (1984 - 1990)

Company Filing History:

goldMedal11 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1977-1990

Loading Chart...
11 patents (USPTO):Explore Patents
1. 4946779 - Pseudo-aminosugars, their production and use (1990-08-07),
2. 4923975 - Valiolamine derivatives and production thereof (1990-05-08),
3. 4827036 - Pseudo-aminosugars, their production and use (1989-05-02),
4. 4803303 - N-substituted pseudo-aminosugars, their production and use (1989-02-07),
5. 4777294 - N-substituted pseudo-aminosugars, their production and use (1988-10-11),
6. 4701559 - N-substituted pseudo-aminosugars, their production and use (1987-10-20),
7. 4595678 - N-substituted pseudo-aminosugars and pharmaceutical compositions (1986-06-17),
8. 4486602 - Valienamine derivatives, their production and use (1984-12-04),
9. 4089947 - Antibiotic compositions containing validamycin compounds (1978-05-16),
10. 4065615 - Deoxyaminoglycoside antibiotic derivatives (1977-12-27),
11. 4011391 - Validamycin C, D, E and F antibiotics (1977-03-08),

Title: Innovations of Yukihiko Kameda

Introduction

Yukihiko Kameda is a prominent inventor based in Kanazawa, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds that have potential therapeutic applications. With a total of 11 patents to his name, Kameda's work focuses on addressing hyperglycemic symptoms and related disorders.

Latest Patents

Kameda's latest patents include the development of pseudo-aminosugars, specifically 5-amino-1-hydroxymethyl-1,2,3,4-cyclohexanetetrol. These compounds exhibit excellent .alpha.-glucosidase inhibitory activity, making them useful for managing hyperglycemic symptoms and various disorders caused by hyperglycemia. Another notable patent involves valiolamine derivatives, which are useful starting materials for creating more potent .alpha.-glucosidase inhibiting compounds. The production of these derivatives involves cultivating Streptomyces hygroscopics in a culture medium and recovering the resulting compounds from the culture broth.

Career Highlights

Kameda is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to focus on innovative research and development in the field of medicinal chemistry. His contributions have been instrumental in advancing the understanding of compounds that can aid in the treatment of metabolic disorders.

Collaborations

Kameda has collaborated with notable colleagues such as Satoshi Horii and Hiroshi Fukase. These collaborations have fostered a productive research environment, leading to the successful development of various innovative compounds.

Conclusion

Yukihiko Kameda's work exemplifies the impact of innovative research in the field of biochemistry. His patents and collaborations highlight his commitment to advancing therapeutic solutions for hyperglycemic conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…